Marzena Pander

Marzena Pander

Auto-generated profile, based on publicly available information

Marzena Pander

Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Kraków, Poland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
MPMarzena Pander
Marzena Pander
MJMateusz Janeta
Mateusz Janeta
Wojciech BuryWojciech Bury
Wojciech Bury
We have devised a straightforward tandem postsynthetic modification strategy for Zr-based metal–organic framework (MOF) materials, which resulted in a series of well-defined 2-in-1 heterogeneous catalysts, cat1–cat8, exhibiting high catalytic activity in the synthesis of cyclic carbonates under solvent-free and co-catalyst-free conditions. The materials feature precisely located co-catalyst moieties decorating the metal nodes throughout the bulk of the MOF and yield cyclic carbonates with up to 99% efficiency at room temperature. We use diffuse reflectance infrared Fourier transform (DRIFT) and solid-state nuclear magnetic resonance (NMR) measurements to elucidate the role of each component in this model catalytic reaction. Establishing a method to precisely control the co-catalyst loading allowed us to observe the cooperativity between Lewis acid sites and the co-catalyst in the 2-in-1 heterogeneous system.

19 January 2023 in Materials Horizons
Verified
Journal Article
Open access
PDF file
MPMarzena Pander
Marzena Pander
RGRodrigo Gil-San-Millan
Rodrigo Gil-San-Millan
PDPedro Delgado
Pedro Delgado
CPCristina Perona-Bermejo
Cristina Perona-Bermejo
UKUrszula Kostrzewa
Urszula Kostrzewa
Wojciech BuryWojciech Bury
Wojciech Bury
A simple yet powerful strategy of carrying out free radical polymerization of methacrylate monomers using a MOF-based initiator. The obtained composites maintain high catalytic activity towards a chemical warfare agent (CWA) simulant.

1 December 2018 in Polyhedron
Verified
Journal Article
Closed access
MPMarzena Pander
Marzena Pander
AŻAnna Żelichowska
Anna Żelichowska
Wojciech BuryWojciech Bury
Wojciech Bury

7 September 2021 in Chemistry of Materials
Verified
Journal Article
Open access
DJDamian Jędrzejowski
Damian Jędrzejowski
MPMarzena Pander
Marzena Pander
WNWojciech Nitek
Wojciech Nitek
Wojciech BuryWojciech Bury
Wojciech Bury
DMDariusz Matoga
Dariusz Matoga
Post-synthetic modifications of metal–organic frameworks (MOFs) enable synthesis of materials with enhanced performance characteristics or those inaccessible by direct synthetic routes. In this work, for the first time, we utilize inverse-electron demand Diels–Alder (iEDDA) modification to control the structural flexibility and porosity of an open framework material. We selected a series of dienophiles with increasing bulkiness including ethyl vinyl ether (eve), cyclohexene (chx), norbornene (nor), and 5-norbornene-2-methanol (noh) to modify a tetrazine-based linker (3,6-dipyridyl-1,2,4,5-tetrazine, dpt) incorporated in a unique doubly interpenetrated 3D hybrid MOF–HOF porous material (HOF, hydrogen-bonded organic framework), {[Cd2(coh)2(dpt)2]·guests}n (JUK-20). Each subnetwork in JUK-20 is built of 2D coordination layers stacked by strong complementary C═O···H–N hydrogen bonds between carbohydrazide dibenzoate linkers (coh). By using the [4 + 2] click reactions of JUK-20, which proceed in a prominent single-crystal-to-single-crystal manner, we obtained a series of JUK-20-dienophile MOFs. The modifications lead to a stepwise decrease in structural flexibility of the JUK-20 platform until the highest rigidity and stability is reached for JUK-20-noh. Consequently, the adsorption capacity in the JUK-20-dienophile series increases, as revealed collectively by single-crystal X-ray diffraction, physisorption isotherms (N2, CO2, and MeOH), and grand canonical Monte Carlo simulations. Our work demonstrates that post-synthetic iEDDA modification is a versatile and efficient tool for systematic functionalization of open framework materials under mild conditions.

6 May 2024 in ACS Applied Electronic Materials
Verified
Journal Article
Closed access
MKMinhyuk Kim
Minhyuk Kim
MPMarzena Pander
Marzena Pander
HMHoi Ri Moon
Hoi Ri Moon

14 June 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
Przemysław JodłowskiPrzemysław Jodłowski
Przemysław Jodłowski
KDKlaudia Dymek
Klaudia Dymek
GKGrzegorz Kurowski
Grzegorz Kurowski
Jolanta JaskowskaJolanta Jaskowska
Jolanta Jaskowska
Wojciech BuryWojciech Bury
Wojciech Bury
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara
In this study, we present a complementary approach for obtaining an effective drug, based on acriflavine (ACF) and zirconium-based metal-organic frameworks (MOFs), against SARS-CoV-2. The experimental results showed that acriflavine inhibits the interaction between viral receptor-binding domain (RBD) of spike protein and angiotensin converting enzyme-2 (ACE2) host receptor driving viral cell entry. The prepared ACF@MOF composites exhibited low (MOF-808 and UiO-66) and high (UiO-67 and NU-1000) ACF loadings. The drug release profiles from prepared composites showed different release kinetics depending on the local pore environment. The long-term ACF release with the effective antiviral ACF concentration was observed for all studied ACF@MOF composites. The density functional theory (DFT) calculations allowed us to determine that π-π stacking together with electrostatic interaction plays an important role in acriflavine adsorption and release from ACF@MOF composites. The molecular docking results have shown that acriflavine interacts with several possible binding sites within the RBD and binding site at the RBD/ACE2 interface. The cytotoxicity and ecotoxicity results have confirmed that the prepared ACF@MOF composites may be considered potentially safe for living organisms. The complementary experimental and theoretical results presented in this study have confirmed that the ACF@MOF composites may be considered a potential candidate for the COVID-19 treatment, which makes them good candidates for clinical trials.